They do not distinguish between muscle and fat, nor do they measure fat distribution
Even simple habits like a brisk walk after meals can improve glucose control and support a natural GLP-1 boost (NIH)
See our GLP-1 weight loss plan online and Meet Your Provider
Summary: Retatrutide, an investigational GLP-1/GIP/glucagon triple agonist, most commonly causes gastrointestinal side effects, and no direct human fertility data currently exist, though indirect reproductive benefits via weight loss are plausible
Side effects are most common during these early weeks, particularly gastrointestinal symptoms like nausea
As of 2023, Novo Nordisk (the manufacturer of Wegovy) stated that its semaglutide was produced only at its own facilities in Denmark